Bristol Myers Squibb Reports Officer Changes & Financials
Ticker: CELG-RI · Form: 8-K · Filed: Jul 25, 2025 · CIK: 14272
| Field | Detail |
|---|---|
| Company | Bristol Myers Squibb Co (CELG-RI) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-change, director-election, debt-issuance, financial-statements
Related Tickers: BMY
TL;DR
BMY filed 8-K: Officer changes, director elections, and financial updates including CVRs and $750M notes.
AI Summary
Bristol Myers Squibb Company (BMY) filed an 8-K on July 25, 2025, reporting events as of July 21, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits, specifically mentioning the Celgene Contingent Value Rights, $750 million in notes due 2035, and common stock.
Why It Matters
This filing indicates potential shifts in leadership or executive compensation at Bristol Myers Squibb, which could impact the company's strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors or officers, especially if accompanied by details on compensatory arrangements, can signal internal shifts that may affect company strategy or performance.
Key Numbers
- $750 million — Notes Due 2035 (Debt issuance reported in the filing.)
Key Players & Entities
- Bristol Myers Squibb Company (company) — Registrant
- Celgene Contingent Value Rights (dollar_amount) — Financial item
- $750 million (dollar_amount) — Notes due 2035
FAQ
Who has departed from Bristol Myers Squibb's board or officer positions?
The filing indicates the departure of directors or certain officers, but specific names are not detailed in the provided text.
Were new directors or officers appointed?
Yes, the filing explicitly mentions the election of directors and the appointment of certain officers.
What is the total value of the notes due 2035?
The filing mentions 'One750NotesDue2035Member', indicating notes due in 2035, with a value of $750 million.
Are there any specific compensatory arrangements mentioned for officers?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item of information, suggesting such arrangements are detailed.
What is the significance of the Celgene Contingent Value Rights mentioned?
The 'CelgeneContingentValueRightsMember' indicates that these rights, likely related to the acquisition of Celgene, are a subject of this filing.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding BRISTOL MYERS SQUIBB CO (CELG-RI).